V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10382967 | 10040537 | 1.66 | 63.4 | null | 2020-02-04 | 2020-02-04 | MUK 5 TRIAL | 02 | null | BCG | 101403009 |
| 10383005 | 10040539 | 1.82 | 61.35 | Palliative (P) | 2019-12-03 | 2019-12-03 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | Y | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101551163 |
| 10383012 | 10040540 | 1.71 | 92 | Palliative (P) | 2020-02-04 | 2020-02-05 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100462573 |
| 10383097 | 10040543 | 1.67 | 87 | Palliative (P) | 2022-02-01 | 2022-02-05 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100567721 |
| 10383158 | 10040545 | 1.65 | 0 | Adjuvant (A) | 2019-06-04 | 2019-06-04 | CHOP | N | null | SUNITINIB | 100700369 |
| 10383160 | 10040546 | 1.75 | 74.3 | null | 2019-09-13 | 2019-09-20 | CHLORAMBUCIL + RITUXIMAB | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100302929 |
| 10383224 | 10040547 | 1.81 | 79 | Curative (C) | 2022-03-14 | 2022-03-19 | CHOP | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100553735 |
| 10383295 | 10040548 | null | 63.8 | null | 2021-03-22 | 2021-03-31 | Sunitinib | 02 | N | VENETOCLAX | 100508251 |
| 10383425 | 10040551 | 0 | 0 | Curative (C) | 2018-07-20 | 2018-07-27 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | CISPLATIN + VINORELBINE | 100017531 |
| 10383452 | 10040552 | 1.78 | 73 | null | null | 2020-10-30 | Cladribine IV (5 day) | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100559600 |
| 10383460 | 10040553 | 1.58 | 79.1 | Curative (C) | 2016-07-26 | 2016-07-26 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100467627 |
| 10383508 | 10040554 | 1.75 | 63.1 | Palliative (P) | 2019-04-19 | 2019-04-21 | BUSULFAN | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101574056 |
| 10383540 | 10040555 | 1.77 | 97.85 | 02 | 2021-09-14 | 2021-10-05 | Palbociclib | N | N | PALBOCICLIB | 100752882 |
| 10383622 | 10040556 | 1.78 | 65 | null | 2016-09-18 | 2016-09-18 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100755252 |
| 10383674 | 10040561 | 1.66 | 74.8 | Palliative (P) | 2019-03-02 | 2019-03-09 | Irinotecan + Modified De Gramont | 01 | N | FLUOROURACIL + IRINOTECAN | 101688838 |
| 10383685 | 10040562 | 1.69 | 115.5 | Adjuvant (A) | 2017-04-02 | 2017-04-16 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100007847 |
| 10383722 | 10040563 | 1.7 | 84.2 | Curative (C) | 2021-11-17 | 2021-11-17 | Acalabrutinib | 02 | N | ACALABRUTINIB | 101266232 |
| 10383748 | 10040564 | 1.57 | 62 | Curative (C) | 2018-05-15 | 2018-06-05 | Cyclophosphamide + Docetaxel | 02 | null | VENETOCLAX | 101258931 |
| 10383756 | 10040565 | 1.56 | 72.5 | 03 | 2019-10-02 | 2019-10-03 | null | 02 | N | BCG | 101792156 |
| 10383758 | 10040566 | 1.77 | null | 03 | 2018-01-28 | 2018-01-28 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100732005 |
| 10383761 | 10040567 | 1.65 | 72.4 | null | 2018-11-22 | 2018-11-23 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 101217063 |
| 10383796 | 10040568 | null | 74 | null | 2019-08-26 | 2019-08-26 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 101845566 |
| 10383819 | 10040569 | null | 0 | Adjuvant (A) | 2020-06-30 | 2020-07-09 | BUSULFAN | 02 | N | POMALIDOMIDE | 100441465 |
| 10383909 | 10040572 | 1.6 | 72 | null | 2020-08-26 | 2020-08-26 | Avelumab | 02 | null | AVELUMAB | 101124455 |
| 10383929 | 10040573 | null | null | null | 2018-06-10 | 2018-06-18 | Bortezomib +/- Dexamethasone | 02 | null | BORTEZOMIB | 100114526 |
| 10383944 | 10040574 | 1.69 | 71 | Adjuvant (A) | 2017-11-13 | 2017-11-18 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100145207 |
| 10384006 | 10040576 | 1.71 | 96.5 | 03 | 2017-12-05 | 2017-12-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101054517 |
| 10384052 | 10040577 | 1.81 | 79 | Curative (C) | 2017-12-24 | 2018-01-22 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100632773 |
| 10384137 | 10040579 | null | null | null | 2018-05-06 | 2018-05-08 | DARATUMUMAB | N | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101193089 |
| 10384180 | 10040580 | 1.62 | 90.6 | null | 2019-06-13 | 2019-06-28 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100562006 |
| 10384189 | 10040581 | 1.55 | 75.3 | Palliative (P) | 2019-02-09 | 2019-02-09 | BCG Intravesical | 02 | N | BUSULFAN | 101221939 |
| 10384203 | 10040583 | 1.5 | 51.3 | Palliative (P) | 2019-02-13 | 2019-02-28 | FLUOROURACIL | 02 | Y | FLUOROURACIL | 101617501 |
| 10384208 | 10040584 | 1.81 | 51 | null | 2017-05-19 | 2017-05-19 | CHLORAMBUCIL + RITUXIMAB | 02 | N | CHLORAMBUCIL + RITUXIMAB | 101131757 |
| 10384229 | 10040585 | 1.78 | 68.5 | Palliative (P) | 2021-04-14 | 2021-04-22 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100522811 |
| 10384241 | 10040586 | 1.81 | 92.3 | Palliative (P) | 2018-08-20 | 2018-08-20 | FLUOROURACIL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101660022 |
| 10384319 | 10040587 | 1.76 | 68.5 | Palliative (P) | 2019-08-09 | 2019-08-10 | Cyclophosphamide + Docetaxel | 02 | N | SUNITINIB | 100176167 |
| 10384376 | 10040588 | 1.74 | null | null | 2018-10-28 | 2020-01-18 | FLUOROURACIL + IRINOTECAN | 2 | null | FLUOROURACIL + IRINOTECAN | 101459140 |
| 10384394 | 10040589 | 1.58 | 67.1 | Adjuvant (A) | 2017-04-02 | 2017-04-02 | Sunitinib | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101024230 |
| 10384438 | 10040590 | 1.82 | 67.9 | Adjuvant (A) | null | 2019-11-06 | Palbociclib | 02 | N | PALBOCICLIB | 100017540 |
| 10384452 | 10040591 | 1.6 | 53.25 | 03 | 2019-05-20 | 2019-05-22 | null | 02 | N | CAPECITABINE + CISPLATIN | 101506952 |
| 10384468 | 10040592 | 1.52 | 83.8 | null | 2021-11-02 | 2021-11-02 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100685615 |
| 10384537 | 10040595 | 1.82 | 70.3 | null | 2021-10-08 | 2021-10-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101390387 |
| 10384587 | 10040597 | 1.63 | 58.2 | Palliative (P) | 2018-08-04 | 2018-08-19 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CAPECITABINE + CISPLATIN | 100065723 |
| 10384653 | 10040598 | null | null | null | 2020-01-01 | 2020-01-10 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101593480 |
| 10384668 | 10040599 | 1.75 | 46 | Neo-adjuvant (N) | 2019-12-28 | 2019-12-28 | CHOP R - 21 days | 02 | N | CHOP R | 101840880 |
| 10384689 | 10040600 | 1.8 | 67.85 | 03 | 2020-09-29 | 2020-09-30 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100059023 |
| 10384696 | 10040601 | null | null | null | 2018-07-05 | 2018-08-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | null | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101210423 |
| 10384791 | 10040602 | 1.86 | null | Palliative (P) | 2019-12-07 | 2019-12-16 | DARATUMUMAB | N | N | CLADRIBINE | 100291406 |
| 10384807 | 10040604 | 1.55 | 97.85 | Palliative (P) | 2021-07-26 | 2021-08-02 | CISPLATIN + FLUOROURACIL | 02 | null | CYTARABINE | 101574498 |
| 10384924 | 10040606 | 1.78 | 103.6 | Neo-adjuvant (N) | 2019-06-20 | 2019-07-04 | DABRAFENIB + TRAMETINIB | 02 | N | DARATUMUMAB | 100000983 |